255 related articles for article (PubMed ID: 32442973)
1. Validation of a scoring system to evaluate the risk of rapid growth of intracranial meningiomas in neurofibromatosis type 2 patients.
Abi Jaoude S; Peyre M; Degos V; Goutagny S; Parfait B; Kalamarides M
J Neurosurg; 2020 May; 134(5):1377-1385. PubMed ID: 32442973
[TBL] [Abstract][Full Text] [Related]
2. A novel weighted scoring system for estimating the risk of rapid growth in untreated intracranial meningiomas.
Lee EJ; Kim JH; Park ES; Kim YH; Lee JK; Hong SH; Cho YH; Kim CJ
J Neurosurg; 2017 Nov; 127(5):971-980. PubMed ID: 28084908
[TBL] [Abstract][Full Text] [Related]
3. Natural history and volumetric analysis of meningiomas in neurofibromatosis type 2.
Oyem PC; de Andrade EJ; Soni P; Murayi R; Obiri-Yeboah D; Lopez D; Kshettry VR; Recinos PF
Neurosurg Focus; 2022 May; 52(5):E5. PubMed ID: 35535826
[TBL] [Abstract][Full Text] [Related]
4. Clinical course and management of intracranial meningiomas in neurofibromatosis type 2 patients.
Nowak A; Dziedzic T; Czernicki T; Kunert P; Marchel A
Neurol Neurochir Pol; 2015; 49(6):367-72. PubMed ID: 26652870
[TBL] [Abstract][Full Text] [Related]
5. Growth prediction in asymptomatic meningiomas: the utility of the AIMSS score.
Brugada-Bellsolà F; Teixidor Rodríguez P; Rodríguez-Hernández A; Garcia-Armengol R; Tardáguila M; González-Crespo A; Domínguez CJ; Rimbau JM
Acta Neurochir (Wien); 2019 Nov; 161(11):2233-2240. PubMed ID: 31489530
[TBL] [Abstract][Full Text] [Related]
6. Long-term natural history of neurofibromatosis Type 2-associated intracranial tumors.
Dirks MS; Butman JA; Kim HJ; Wu T; Morgan K; Tran AP; Lonser RR; Asthagiri AR
J Neurosurg; 2012 Jul; 117(1):109-17. PubMed ID: 22503123
[TBL] [Abstract][Full Text] [Related]
7. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.
Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV
BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203
[TBL] [Abstract][Full Text] [Related]
8. Convexity Meningiomas in Patients with Neurofibromatosis Type 2: Long-Term Outcomes After Gamma Knife Radiosurgery.
Ruiz-Garcia H; Trifiletti DM; Mohammed N; Hung YC; Xu Z; Chytka T; Liscak R; Tripathi M; Arsanious D; Cifarelli CP; Caceres MP; Mathieu D; Speckter H; Lekovic GP; Mehta GU; Sheehan JP
World Neurosurg; 2021 Feb; 146():e678-e684. PubMed ID: 33152493
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of 287 meningiomas in neurofibromatosis type 2 patients: clinical, radiological, and molecular features.
Goutagny S; Bah AB; Henin D; Parfait B; Grayeli AB; Sterkers O; Kalamarides M
Neuro Oncol; 2012 Aug; 14(8):1090-6. PubMed ID: 22711605
[TBL] [Abstract][Full Text] [Related]
10. Correlation of volumetric growth and histological grade in 50 meningiomas.
Soon WC; Fountain DM; Koczyk K; Abdulla M; Giri S; Allinson K; Matys T; Guilfoyle MR; Kirollos RW; Santarius T
Acta Neurochir (Wien); 2017 Nov; 159(11):2169-2177. PubMed ID: 28791500
[TBL] [Abstract][Full Text] [Related]
11. Effect of bevacizumab on intracranial meningiomas in patients with neurofibromatosis type 2 - a retrospective case series.
Alanin MC; Klausen C; Caye-Thomasen P; Thomsen C; Fugleholm K; Poulsgaard L; Lassen U; Mau-Sorensen M; Hofland KF
Int J Neurosci; 2016 Nov; 126(11):1002-6. PubMed ID: 26365467
[TBL] [Abstract][Full Text] [Related]
12. Cranial meningiomas in 411 neurofibromatosis type 2 (NF2) patients with proven gene mutations: clear positional effect of mutations, but absence of female severity effect on age at onset.
Smith MJ; Higgs JE; Bowers NL; Halliday D; Paterson J; Gillespie J; Huson SM; Freeman SR; Lloyd S; Rutherford SA; King AT; Wallace AJ; Ramsden RT; Evans DG
J Med Genet; 2011 Apr; 48(4):261-5. PubMed ID: 21278391
[TBL] [Abstract][Full Text] [Related]
13. Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations.
Kalamarides M; Stemmer-Rachamimov AO; Takahashi M; Han ZY; Chareyre F; Niwa-Kawakita M; Black PM; Carroll RS; Giovannini M
Brain Pathol; 2008 Jan; 18(1):62-70. PubMed ID: 17924978
[TBL] [Abstract][Full Text] [Related]
14. Intracranial meningiomas and neurofibromatosis type 2.
Aboukais R; Zairi F; Baroncini M; Bonne NX; Schapira S; Vincent C; Lejeune JP
Acta Neurochir (Wien); 2013 Jun; 155(6):997-1001; discussion 1001. PubMed ID: 23558725
[TBL] [Abstract][Full Text] [Related]
15. The value of diffusion-weighted imaging in the natural history of meningiomas: a predictor of tumor growth.
Zhang R; Wang Z; Zheng H; Chen X; Chen H; Song Y; Liu Z; Xue Y; Lin L
J Neurosurg; 2024 Feb; 140(2):377-385. PubMed ID: 37877959
[TBL] [Abstract][Full Text] [Related]
16. Gamma Knife radiosurgery for meningiomas in patients with neurofibromatosis Type 2.
Liu A; Kuhn EN; Lucas JT; Laxton AW; Tatter SB; Chan MD
J Neurosurg; 2015 Mar; 122(3):536-42. PubMed ID: 25555193
[TBL] [Abstract][Full Text] [Related]
17. A role for the p53 pathway in the pathology of meningiomas with NF2 loss.
Chang Z; Guo CL; Ahronowitz I; Stemmer-Rachamimov AO; MacCollin M; Nunes FP
J Neurooncol; 2009 Feb; 91(3):265-70. PubMed ID: 18974932
[TBL] [Abstract][Full Text] [Related]
18. Pediatric cerebellopontine angle and internal auditory canal tumors: clinical article.
Holman MA; Schmitt WR; Carlson ML; Driscoll CL; Beatty CW; Link MJ
J Neurosurg Pediatr; 2013 Oct; 12(4):317-24. PubMed ID: 23909617
[TBL] [Abstract][Full Text] [Related]
19. Meningiomas in patients with neurofibromatosis type 2 predominantly comprise 'immunogenic subtype' tumours characterised by macrophage infiltration.
Teranishi Y; Miyawaki S; Nakatochi M; Okano A; Ohara K; Hongo H; Ishigami D; Sakai Y; Shimada D; Takayanagi S; Ikemura M; Komura D; Katoh H; Mitsui J; Morishita S; Ushiku T; Ishikawa S; Nakatomi H; Saito N
Acta Neuropathol Commun; 2023 Sep; 11(1):156. PubMed ID: 37752594
[TBL] [Abstract][Full Text] [Related]
20. The Role of Pre-Operative MRI for Prediction of High-Grade Intracranial Meningioma: A Retrospective Study.
Radeesri K; Lekhavat V
Asian Pac J Cancer Prev; 2023 Mar; 24(3):819-825. PubMed ID: 36974533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
